Published in J Virol on November 01, 1990
Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication. J Virol (1994) 2.37
Characterization of large deletions occurring during a single round of retrovirus vector replication: novel deletion mechanism involving errors in strand transfer. J Virol (1991) 2.34
The remarkable frequency of human immunodeficiency virus type 1 genetic recombination. Microbiol Mol Biol Rev (2009) 2.02
Long terminal repeat enhancer core sequences in proviruses adjacent to c-myc in T-cell lymphomas induced by a murine retrovirus. J Virol (1995) 1.43
A model system for nonhomologous recombination between retroviral and cellular RNA. J Virol (1993) 1.32
Effects of limiting homology at the site of intermolecular recombinogenic template switching during Moloney murine leukemia virus replication. J Virol (2001) 1.06
Construction and characterization of a replication-competent retroviral shuttle vector plasmid. J Virol (2002) 1.03
Efficient and specific internal cleavage of a retroviral palindromic DNA sequence by tetrameric HIV-1 integrase. PLoS One (2007) 0.94
Characterization of unintegrated retroviral DNA with long terminal repeat-associated cell-derived inserts. J Virol (1992) 0.93
The kissing-loop motif is a preferred site of 5' leader recombination during replication of SL3-3 murine leukemia viruses in mice. J Virol (1999) 0.89
Retrovirus-mediated gene transfer to cystic fibrosis airway epithelial cells: effect of selectable marker sequences on long-term expression. Nucleic Acids Res (1993) 0.89
Genetic analysis of the Rous sarcoma virus subgroup D env gene: mammal tropism correlates with temperature sensitivity of gp85. J Virol (1991) 0.88
Transduction of cellular sequence by a human immunodeficiency virus type 1-derived vector. J Virol (2001) 0.86
Human immunodeficiency virus type 1 transductive recombination can occur frequently and in proportion to polyadenylation signal readthrough. J Virol (2004) 0.86
Rous sarcoma virus (RSV) integration in vivo: a CA dinucleotide is not required in U3, and RSV linear DNA does not autointegrate. J Virol (2007) 0.85
Extended minus-strand DNA as template for R-U5-mediated second-strand transfer in recombinational rescue of primer binding site-modified retroviral vectors. J Virol (1998) 0.82
Evidence for the acquisition of multi-drug resistance in an HIV-1 clinical isolate via human sequence transduction. Virology (2006) 0.81
Effects of identity minimization on Moloney murine leukemia virus template recognition and frequent tertiary template-directed insertions during nonhomologous recombination. J Virol (2007) 0.80
Negative regulation of the 5' long terminal repeat (LTR) by the 3' LTR in the murine proviral genome. J Virol (1994) 0.78
Selection of functional tRNA primers and primer binding site sequences from a retroviral combinatorial library: identification of new functional tRNA primers in murine leukemia virus replication. Nucleic Acids Res (2000) 0.78
New nucleotide sequence data on the EMBL File Server. Nucleic Acids Res (1991) 0.75
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
Construction and characterization of new cloning vehicles. II. A multipurpose cloning system. Gene (1977) 114.87
Selective extraction of polyoma DNA from infected mouse cell cultures. J Mol Biol (1967) 106.91
Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79
High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res (1988) 34.78
Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci U S A (1987) 18.91
Nucleotide sequence of Rous sarcoma virus. Cell (1983) 17.80
Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5. Gene (1982) 13.62
A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev (1989) 8.80
New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol Cell Biol (1984) 8.63
Structure, replication, and recombination of retrovirus genomes: some unifying hypotheses. J Gen Virol (1979) 7.69
Molecular cloning and characterization of avian sarcoma virus circular DNA molecules. J Virol (1980) 7.37
Continuous tissue culture cell lines derived from chemically induced tumors of Japanese quail. Cell (1977) 7.23
Analysis of avian leukosis virus DNA and RNA in bursal tumours: viral gene expression is not required for maintenance of the tumor state. Cell (1981) 6.98
Structure of a cloned circular Moloney murine leukemia virus DNA molecule containing an inverted segment: implications for retrovirus integration. Proc Natl Acad Sci U S A (1980) 6.73
Point mutants of Moloney murine leukemia virus that fail to package viral RNA: evidence for specific RNA recognition by a "zinc finger-like" protein sequence. Proc Natl Acad Sci U S A (1988) 6.44
Characterization of Moloney murine leukemia virus mutants with single-amino-acid substitutions in the Cys-His box of the nucleocapsid protein. J Virol (1989) 5.47
Rous sarcoma virus nucleic acid-binding protein p12 is necessary for viral 70S RNA dimer formation and packaging. J Virol (1986) 4.85
Covalently closed circular DNA of avian sarcoma virus: purification from nuclei of infected quail tumor cells and measurement by electron microscopy and gel electrophoresis. J Mol Biol (1976) 4.65
A new method for the purification and identification of covalently closed circular DNA molcules. Nucleic Acids Res (1978) 4.09
Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site. J Virol (1982) 4.06
Kinetics of synthesis, structure and purification of avian sarcoma virus-specific DNA made in the cytoplasm of acutely infected cells. J Mol Biol (1978) 4.04
A conserved cis-acting sequence in the 5' leader of avian sarcoma virus RNA is required for packaging. J Virol (1986) 3.95
Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements. Proc Natl Acad Sci U S A (1981) 3.82
Intramolecular integration within Moloney murine leukemia virus DNA. J Virol (1981) 3.77
Broad spectrum of in vivo forward mutations, hypermutations, and mutational hotspots in a retroviral shuttle vector after a single replication cycle: deletions and deletions with insertions. Proc Natl Acad Sci U S A (1990) 3.76
Nucleotide sequence analysis of the long terminal repeat (LTR) of avian retroviruses: structural similarities with transposable elements. Cell (1980) 3.53
Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. Proc Natl Acad Sci U S A (1983) 3.41
Mutations in the gag gene of Moloney murine leukemia virus: effects on production of virions and reverse transcriptase. J Virol (1984) 3.14
Integration of retroviral DNA. Curr Top Microbiol Immunol (1990) 2.66
Generation of novel, biologically active Harvey sarcoma viruses via apparent illegitimate recombination. J Virol (1981) 2.53
Nucleotide sequence of the 5' noncoding region and part of the gag gene of Rous sarcoma virus. J Virol (1982) 2.53
Mutagenesis of the region between env and src of the SR-A strain of Rous sarcoma virus for the purpose of constructing helper-independent vectors. Virology (1984) 2.38
Unraveling retrovirus integration. Cell (1990) 2.35
Mutations in gag proteins P12 and P15 of Moloney murine leukemia virus block early stages of infection. J Virol (1984) 2.30
env genes of avian retroviruses: nucleotide sequence and molecular recombinants define host range determinants. Virology (1986) 2.11
Genetic evidence that the avian retrovirus DNA endonuclease domain of pol is necessary for viral integration. J Virol (1988) 2.03
Involvement of directly repeated sequences in the generation of deletions of the avian sarcoma virus src gene. J Virol (1983) 1.94
Patterns of proviral insertion and deletion in avian leukosis virus-induced lymphomas. J Virol (1986) 1.93
Structure of a cloned circular retroviral DNA containing a tRNA sequence between the terminal repeats. J Virol (1986) 1.72
Efficient packaging of readthrough RNA in ALV: implications for oncogene transduction. Science (1987) 1.65
A new pathway in the generation of defective retrovirus DNA. J Virol (1985) 1.44
Evolutionary variants of Rous sarcoma virus: large deletion mutants do not result from homologous recombination. J Virol (1985) 1.39
Genetic recombination in avian retroviruses. J Cell Biochem (1982) 1.37
5' long terminal repeats of myc-associated proviruses appear structurally intact but are functionally impaired in tumors induced by avian leukosis viruses. J Virol (1987) 1.25
Retroviral transduction of oncogenic sequences involves viral DNA instead of RNA. Proc Natl Acad Sci U S A (1988) 1.17
Polymerase-defective mutant of the Bryan high-titer strain of Rous sarcoma virus. Nucleic Acids Res (1986) 1.08
3'-Azido-3'-deoxythymidine inhibits the replication of avian leukosis virus. J Virol (1987) 0.98
Long terminal repeat (LTR)-derived recombination of retroviral DNA: sequence analyses of an aberrant clone of baboon endogenous virus DNA which carries an inversion from the LTR to the gag region. Nucleic Acids Res (1982) 0.97
Identification and characterization of dimeric and trimeric circular forms of avian sarcoma virus-specific DNA. Virology (1980) 0.95
Frequent partial deletion of human adult T-cell leukemia virus type I proviruses in experimental transmission: pattern and possible implication. J Virol (1986) 0.94
Site-directed mutagenesis of the avian retrovirus nucleocapsid protein, pp 12, at Serine 40, the primary site of phosphorylation in vivo. J Biol Chem (1988) 0.90
Monomer and multimer covalently closed circular forms of Rous sarcoma virus DNA. J Virol (1979) 0.83
Avian retrovirus integration protein: structure-functional analysis of viable mutants. Virology (1989) 0.79
X-ray intensifying screens greatly enhance the detection by autoradiography of the radioactive isotopes 32P and 125I. Anal Biochem (1978) 10.28
Complete mutagenesis of the HIV-1 protease. Nature (1989) 5.16
Rapid evolution of reproductive isolation in the wild: evidence from introduced salmon. Science (2000) 5.00
Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-poisson distribution of transmitted variants. J Virol (2009) 4.40
A 32,000-dalton nucleic acid-binding protein from avian retravirus cores possesses DNA endonuclease activity. Virology (1978) 4.35
Retrovirus envelope glycoproteins. Curr Top Microbiol Immunol (1990) 4.22
Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants. J Virol (1999) 4.16
The p2 domain of human immunodeficiency virus type 1 Gag regulates sequential proteolytic processing and is required to produce fully infectious virions. J Virol (1994) 3.95
Nucleotide sequence of cloned unintegrated avian sarcoma virus DNA: viral DNA contains direct and inverted repeats similar to those in transposable elements. Proc Natl Acad Sci U S A (1981) 3.82
A single subunit from avian myeloblastosis virus with both RNA-directed DNA polymerase and ribonuclease H activity. Proc Natl Acad Sci U S A (1973) 3.71
Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli. Science (1987) 3.46
Transduction of a cellular oncogene: the genesis of Rous sarcoma virus. Proc Natl Acad Sci U S A (1983) 3.41
The nucleotide sequence of an untranslated but conserved domain at the 3' end of the avian sarcoma virus genome. Nucleic Acids Res (1980) 3.16
A critical review of adaptive genetic variation in Atlantic salmon: implications for conservation. Biol Rev Camb Philos Soc (2007) 2.98
Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles. J Virol (1993) 2.96
Analysis of human immunodeficiency virus type 1 nef gene sequences present in vivo. J Virol (1993) 2.94
Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc Natl Acad Sci U S A (1991) 2.80
Macrophage tropism of human immunodeficiency virus type 1 isolates from brain and lymphoid tissues predicts neurotropism independent of coreceptor specificity. J Virol (2001) 2.79
Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis. Nat Genet (1992) 2.79
Improved success of phenotype prediction of the human immunodeficiency virus type 1 from envelope variable loop 3 sequence using neural networks. Virology (2001) 2.74
Virus-coded origin of a 32,000-dalton protein from avian retrovirus cores: structural relatedness of p32 and the beta polypeptide of the avian retrovirus DNA polymerase. J Virol (1978) 2.70
Cleavage of HIV-1 gag polyprotein synthesized in vitro: sequential cleavage by the viral protease. AIDS Res Hum Retroviruses (1989) 2.62
Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease. Proc Natl Acad Sci U S A (1994) 2.59
Nucleotide sequence of the 5' noncoding region and part of the gag gene of Rous sarcoma virus. J Virol (1982) 2.53
The leader sequence of the subgenomic mRNA's of Rous sarcoma virus is approximately 390 nucleotides. J Virol (1982) 2.51
Endonuclease activity of purified RNA-directed DNA polymerase from avian myeloblastosis virus. J Biol Chem (1979) 2.50
Site-specific nicking at the avian retrovirus LTR circle junction by the viral pp32 DNA endonuclease. Nucleic Acids Res (1985) 2.42
Requirement of the avian retrovirus pp32 DNA binding protein domain for replication. Virology (1984) 2.39
V3 loop of the human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J Virol (1993) 2.27
Site-specific mutagenesis of a recombinant anti-single-stranded DNA Fab. Role of heavy chain complementarity-determining region 3 residues in antigen interaction. J Biol Chem (1997) 2.25
Removal of 3'-OH-terminal nucleotides from blunt-ended long terminal repeat termini by the avian retrovirus integration protein. J Virol (1990) 2.25
Avian retrovirus pp32 DNA-binding protein. I. Recognition of specific sequences on retrovirus DNA terminal repeats. J Virol (1982) 2.17
Analysis of retroviral protease cleavage sites reveals two types of cleavage sites and the structural requirements of the P1 amino acid. J Biol Chem (1991) 2.11
env genes of avian retroviruses: nucleotide sequence and molecular recombinants define host range determinants. Virology (1986) 2.11
Amino acid sequence analysis of reverse transcriptase subunits from avian myeloblastosis virus. J Virol (1980) 2.09
Vaccination of macaques against pathogenic simian immunodeficiency virus with Venezuelan equine encephalitis virus replicon particles. J Virol (2000) 2.09
Looking at proteins: representations, folding, packing, and design. Biophysical Society National Lecture, 1992. Biophys J (1992) 2.08
Evolutionary variants of the human immunodeficiency virus type 1 V3 region characterized by using a heteroduplex tracking assay. J Virol (1997) 2.04
Genetic evidence that the avian retrovirus DNA endonuclease domain of pol is necessary for viral integration. J Virol (1988) 2.03
Nuclease mechanism of the avian retrovirus pp32 endonuclease. J Virol (1986) 2.01
Sequence relatedness between the subunits of avian myeloblastosis virus reverse transcriptase. J Biol Chem (1975) 2.01
Ribonuclease H: a ubiquitous activity in virions of ribonucleic acid tumor viruses. J Virol (1972) 1.84
The avian retrovirus env gene family: molecular analysis of host range and antigenic variants. J Virol (1988) 1.83
Nef from primary isolates of human immunodeficiency virus type 1 suppresses surface CD4 expression in human and mouse T cells. J Virol (1993) 1.77
Different mode of action of ribonuclease H in purified alpha and alpha beta ribonucleic acid-directed deoxyribonucleic acid polymerase from avian myeloblastosis virus. J Biol Chem (1974) 1.74
Concerted integration of viral DNA termini by purified avian myeloblastosis virus integrase. J Virol (1992) 1.74
Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues. Cancer Res (2000) 1.73
Humoral, mucosal, and cellular immunity in response to a human immunodeficiency virus type 1 immunogen expressed by a Venezuelan equine encephalitis virus vaccine vector. J Virol (1997) 1.73
The role of Thomsen-Friedenreich antigen in adhesion of human breast and prostate cancer cells to the endothelium. Cancer Res (2001) 1.71
Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32. J Virol (1998) 1.69
Mutational analysis of human immunodeficiency virus type 1 protease suggests functional homology with aspartic proteinases. J Virol (1989) 1.66
Defining nucleic acid-binding properties of avian retrovirus integrase by deletion analysis. J Virol (1991) 1.62
tRNATrp as primer for RNA-directed DNA polymerase: structural determinants of function. J Biol Chem (1979) 1.62
Efficient concerted integration of retrovirus-like DNA in vitro by avian myeloblastosis virus integrase. Nucleic Acids Res (1994) 1.58
Purification and characterization of the DNA polymerase and RNase H activities in Moloney murine sarcoma-leukemia virus. J Virol (1975) 1.56
Characterization of an HIV-1 isolate displaying an apparent absence of virion-associated reverse transcriptase activity. AIDS Res Hum Retroviruses (1991) 1.56
Virus-coded DNA endonuclease from avian retrovirus. J Virol (1981) 1.45
A new pathway in the generation of defective retrovirus DNA. J Virol (1985) 1.44
A multiple-site-specific heteroduplex tracking assay as a tool for the study of viral population dynamics. Proc Natl Acad Sci U S A (2001) 1.41
Unique chromosomal rearrangement and mucin production in a novel salivary myoepithelial cell strain. Arch Otolaryngol Head Neck Surg (1993) 1.41
The regulation of sequential processing of HIV-1 Gag by the viral protease. Adv Exp Med Biol (1998) 1.41
Avian retrovirus pp32 DNA binding protein. Preferential binding to the promoter region of long terminal repeat DNA. Biochemistry (1984) 1.39
Design and characterization of alpha-melanotropin peptide analogs cyclized through rhenium and technetium metal coordination. Proc Natl Acad Sci U S A (1998) 1.39
Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol (2000) 1.38
Migratory costs and the evolution of egg size and number in introduced and indigenous salmon populations. Evolution (2001) 1.37
Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein. Virology (1997) 1.36
Antibodies against a synthetic peptide of the avian retrovirus pp32 protein and the beta DNA polymerase subunit. Virology (1983) 1.36
Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting properties. J Nucl Med (2001) 1.33
Proteolytic processing of the p2/nucleocapsid cleavage site is critical for human immunodeficiency virus type 1 RNA dimer maturation. J Virol (2001) 1.33
Partial phosphorylation in vivo of the avian retrovirus pp32 DNA endonuclease. J Virol (1980) 1.33
Retroviral integration: in vitro host site selection by avian integrase. J Virol (1994) 1.33
Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc Res (1999) 1.30
The terminal redundancy of the retrovirus genome facilitates chain elongation by reverse transcriptase. J Biol Chem (1981) 1.28
Activation of an Mg2+-dependent DNA endonuclease of avian myeloblastosis virus alpha beta DNA polymerase by in vitro proteolytic cleavage. J Virol (1980) 1.27
Diaminopimelate decarboxylase of sporulating bacteria. J Bacteriol (1968) 1.26
Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease. J Virol (1997) 1.22
Patterns of changes in human immunodeficiency virus type 1 V3 sequence populations late in infection. J Virol (2000) 1.21
Correction of the apical membrane chloride permeability defect in polarized cystic fibrosis airway epithelia following retroviral-mediated gene transfer. Hum Gene Ther (1992) 1.20
Mutational sensitivity patterns define critical residues in the palm subdomain of the reverse transcriptase of human immunodeficiency virus type 1. Nucleic Acids Res (1995) 1.19
A genetic approach for identifying critical residues in the fingers and palm subdomains of HIV-1 reverse transcriptase. Proc Natl Acad Sci U S A (1998) 1.19
Assembly and catalytic properties of retrovirus integrase-DNA complexes capable of efficiently performing concerted integration. J Virol (1995) 1.19
An M13 phage library displaying random 38-amino-acid peptides as a source of novel sequences with affinity to selected targets. Gene (1993) 1.19
Sequence requirements of the HIV-1 protease flap region determined by saturation mutagenesis and kinetic analysis of flap mutants. Proc Natl Acad Sci U S A (1997) 1.17
Host site selection for concerted integration by human immunodeficiency virus type-1 virions in vitro. Virology (1997) 1.16
Complete mutagenesis of protein coding domains. Methods Enzymol (1991) 1.16
Different states of avian myeloblastosis virus DNA polymerase and their binding capacity to primer rRNATrp. Virology (1976) 1.15
Effects of Thomsen-Friedenreich antigen-specific peptide P-30 on beta-galactoside-mediated homotypic aggregation and adhesion to the endothelium of MDA-MB-435 human breast carcinoma cells. Cancer Res (2000) 1.15
DNase protection analysis of retrovirus integrase at the viral DNA ends for full-site integration in vitro. J Virol (2001) 1.13
Purification of the alpha subunit of avian myeloblastosis virus DNA polymerase by polyuridylic acid-sepharose. J Virol (1976) 1.12
Dissociation of alpha beta DNA polymerase of avian myeloblastosis virus by dimethyl sulfoxide. J Virol (1976) 1.12
Purification of reverse transcriptase from avian retroviruses using affinity chromatography on heparin-sepharose. J Virol Methods (1980) 1.11
Avian retrovirus U3 and U5 DNA inverted repeats. Role Of nonsymmetrical nucleotides in promoting full-site integration by purified virion and bacterial recombinant integrases. J Biol Chem (1997) 1.10
Identification of surrogate agonists for the human FPRL-1 receptor by autocrine selection in yeast. Nat Biotechnol (1998) 1.10
Genetic variability of the human immunodeficiency virus: statistical and biological issues. Annu Rev Genet (1994) 1.07
Development of an acid-soluble assay for measuring retrovirus integrase 3'-OH terminal nuclease activity. Anal Biochem (1991) 1.07
Repression of diaminopimelate decarboxylase by L-lysine in different Bacillus species. J Bacteriol (1971) 1.06
Mutants of the Rous sarcoma virus reverse transcriptase gene are nondefective in early replication events. J Biol Chem (1985) 1.06